about
Metabolic alterations and hepatitis C: From bench to bedsideThe hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeThe role of endocannabinoids system in fatty liver disease and therapeutic potentialsChronic hepatitis C virus infection and neurological and psychiatric disorders: an overviewInsulin resistance and chronic liver disease.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openingsElevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers.Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injuryShort-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burdenMarijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysisHybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosisExogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells.MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.Pathophysiology of NASH: perspectives for a targeted treatment.Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.Effects of cannabinoids and their receptors on viral infections.The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression.Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes.Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin.Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
P2860
Q26773261-D08B145C-71FC-43D3-9E6C-DE1F14A7C62DQ26850858-F3252753-6CD9-46DE-A06C-6365CC4C42B8Q27009466-0CC344ED-19EC-4CE9-A536-022E7B1EF061Q28082212-DCE5C195-C797-4C54-B63B-1A1AA6A945B8Q35073012-C70CDC85-B941-4EF3-B8DD-CFB806CF0F6EQ35193292-1B2272BA-CF0F-4292-8410-F08A863979D6Q35585455-AF82F16A-1A0D-4FC5-8116-BB66355B466AQ36742010-249A3738-095A-4BCF-BCA6-F5A15433873AQ36795890-8F4B4A7C-8341-4E0C-993E-7B248AF96B49Q36891437-7606AA79-B116-4D1C-B1F7-2424F853C2CFQ37085008-9B9B0BB0-C602-40A6-A5B9-20766875DE1FQ37164508-DBE44E0E-359B-4BBE-810F-153BC9A9F84AQ37190302-8C31A1FB-23F9-4C82-9DD3-D379D077C603Q37264708-C535760F-EA18-4F61-877A-85DD7180D26FQ37699476-AE9E47E8-273B-4FB7-B7E3-4D2921B73A59Q37863141-4C812D16-A3B7-4F49-AB85-A8321D3900C4Q38157936-4BD9DA66-752C-421D-8C88-F4353A591F85Q38522557-E0C6F918-0B60-43AF-ADA1-9C1A0463FC74Q39031169-865E1532-8E59-4ED3-A4AD-5C96B43DAA9EQ40659740-490480AC-C0F3-4FCF-A131-6F9DD60F8C5CQ40813737-2B85F0CD-0401-4EBD-A12E-14DFB3A1382AQ46503559-75A1EE62-447C-429F-B186-389755558AADQ50533517-42FF3C2A-A0DE-412B-92CD-3875F11D77A1Q57821728-5161D4B1-014B-4058-8384-28DC8A0BBE3C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hepatitis C virus induces the cannabinoid receptor 1.
@ast
Hepatitis C virus induces the cannabinoid receptor 1.
@en
type
label
Hepatitis C virus induces the cannabinoid receptor 1.
@ast
Hepatitis C virus induces the cannabinoid receptor 1.
@en
prefLabel
Hepatitis C virus induces the cannabinoid receptor 1.
@ast
Hepatitis C virus induces the cannabinoid receptor 1.
@en
P2093
P2860
P921
P1433
P1476
Hepatitis C virus induces the cannabinoid receptor 1.
@en
P2093
David van der Poorten
Duncan McLeod
Jacob George
Jane S Milliken
Jayshree Sesha
Kayla Tran
Lionel W Hebbard
Mahsa Shahidi
Mark W Douglas
P2860
P304
P356
10.1371/JOURNAL.PONE.0012841
P407
P577
2010-09-17T00:00:00Z